Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

Seung-Hoon Lee; Sang Won Jeon; Cheolmin Shin; Chi-Un Pae; Ashwin A. Patkar; Prakash S. Masand; Hyonggin An; Changsu Han

doi:10.30773/pi.2021.0368e

Search: Psychiatry Investig Search

CLOSE

Psychiatry Investig > Volume 19(6); 2022 > Article

Lee, Jeon, Shin, Pae, Patkar, Masand, An, and Han: Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

Erratum

Psychiatry Investigation 2022;19(6):500.

Published online: June 15, 2022

DOI: https://doi.org/10.30773/pi.2021.0368e

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

Seung-Hoon Lee^1,^*, Sang Won Jeon^2,^*, Cheolmin Shin³, Chi-Un Pae⁴, Ashwin A. Patkar⁵, Prakash S. Masand⁶, Hyonggin An⁷, Changsu Han⁸

¹Department of Psychiatry, Veterans Health Service Medical Center, Seoul, Republic of Korea

²Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

³Department of Psychiatry, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea

⁴Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

⁵Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA

⁶Global Medical Education, New York, NY, USA

⁷Department of Biostatistics, Korea University College of Medicine, Seoul, Republic of Korea

⁸Department of Psychiatry, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

This corrects the article "Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study" in volume 19 on page 268.

Psychiatry Investig 2022;19(4):268-280

https://doi.org/10.30773/pi.2021.0368

In the original publication, the affiliation of the fifth author, Ashwin A. Patkar, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA, was incorrect.

The corrected affiliation is as follows: Department of Advance Psychiatry, Rush University Medical Center, Raleigh, NC, USA.

TOOLS